Hindwell Pharmaceuticals Ltd - Limited company - abbreviated

REGISTERED NUMBER: 01574780 (England and Wales)

Abbreviated Unaudited Accounts

for the Period 1 January 2015 to 30 September 2015

for

Hindwell Pharmaceuticals Ltd

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3

DIRECTORS:

M H G Burke

Mrs C McCoy

K Burke

SECRETARY:

M H G Burke

REGISTERED OFFICE:

3rd Floor Pacific Chambers

11-13 Victoria Street

Liverpool

Merseyside

L2 5QQ

REGISTERED NUMBER:

01574780 (England and Wales)

ACCOUNTANTS:

Haines Watts Liverpool Ltd

incorporating King Nagus Bakerman

H W, Chartered Accountants

Pacific Chambers 11-13 Victoria Street

Liverpool

L2 5QQ

CURRENT ASSETS

Debtors

156,534

CREDITORS

Amounts falling due within one year

154,473

4,473

NET CURRENT ASSETS

2,061

152,061

TOTAL ASSETS LESS CURRENT
LIABILITIES

2,061

152,061

CAPITAL AND RESERVES

Called up share capital

2

100

Profit and loss account

1,961

151,961

SHAREHOLDERS' FUNDS

2,061

152,061

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2015.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 22 March 2016 and were signed on its behalf by:

M H G Burke - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective April 2008).

The company was dormant throughout the current period and previous year.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

2.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.9.15

31.12.14

value:

£

100

Ordinary

£1

100

Hindwell Pharmaceuticals Ltd - Limited company - abbreviated - 11.9

Hindwell Pharmaceuticals Ltd - Limited company - abbreviated - 11.9